Biophotonics Market Report 2026

Biophotonics Market Overview

• Biophotonics market size has reached to $92.07 billion in 2025 • Expected to grow to $166.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Rising Demand For Minimally Invasive Surgeries Boosts Biophotonics Market • Market Trend: Innovations In The Biophotonics Market • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Biophotonics Market?

Biophotonics is the combination of photonics and biology and is a multidisciplinary research field embracing all light-based technologies applied to life sciences and medicine. It is used to examine, control, and track biological processes at various levels of biology: cellular, tissue, molecular, and organism level. The main product technologies in biophotonics are in-vitro and in-vivo. In vitro studies examine microorganisms, cells, and biological molecules outside of their natural biological framework. These studies in biology and its subdisciplines are generally done in labware such as test tubes, flasks, Petri dishes, and microtiter plates, and are referred to as test-tube investigations. The different applications include see-through imaging, inside imaging, spectromolecular, surface imaging, microscopy, light therapy, biosensors, and others and are used by various sectors such as diagnostics, therapeutic, tests, and others.

What Is The Biophotonics Market Growth Forecast?

The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $166.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of personalized medicine applications, rising integration of ai in optical imaging, growing use of biophotonics in minimally invasive therapies, increasing adoption of point-of-care diagnostic devices. Major trends in the forecast period include increasing use of optical imaging in diagnostics, rising adoption of non-invasive light-based therapies, growing integration of biophotonics in medical devices, expansion of high-resolution microscopy techniques, enhanced focus on real-time biological monitoring.

Global Biophotonics Market Segmentation

1) By Product Technology: In-Vitro, In-Vivo 2) By Application: See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications 3) By End Use: Diagnostics, Therapeutic, Tests, Other End Uses Subsegments: 1) By In-Vitro: Diagnostic Imaging, Fluorescence Microscopy, Spectroscopy-Based Detection, Biochemical Sensors, Point-Of-Care Devices 2) By In-Vivo: Endoscopy, Optical Coherence Tomography (OCT), Photodynamic Therapy (PDT), Bioluminescence Imaging, Near-Infrared Spectroscopy (NIRS)

What Is The Driver Of The Biophotonics Market?

Increasing demand for minimally invasive surgeries is expected to propel the growth of the biophotonics market going forward. Optical engineering and imaging technologies have become instrumental in the realm of minimally invasive procedures, enabling real-time visualization of tissue manipulation within remote internal sites. For instance, in June 2024, according to International Society of Aesthetic Plastic Surgery, a US-based non profit professional society, reported that total surgical and non-surgical procedures increased by 3.4% in 2023, up to 34.9 million. Therefore, the expanding number of minimally invasive surgeries conducted worldwide annually is contributing to the enhanced revenues in the biophotonics industry.

Key Players In The Global Biophotonics Market

Major companies operating in the biophotonics market are Thermo Fisher Scientific Inc., OpGen Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co., Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments Plc, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Bioptics Inc.

Global Biophotonics Market Trends and Insights

Major companies operating in the biophotonics market are focusing on developing innovative products such as bronchoscopes for advanced procedures in the medical field. Bronchoscopes are medical instruments used for examining the inside of the respiratory system. For instance, in September 2025, Olympus Corporation, a Japan‑based precision optics and medical device manufacturer, launched the BF‑UCP190F, a new endobronchial ultrasound (EBUS) bronchoscope optimized for lung lesion biopsy and advanced diagnostic procedures. The device features a slim 5.9 mm outer diameter and 170° upward angulation, allowing physicians to navigate deep into the peribronchial region and improve access to segmental and subsegmental airways. This launch strengthens Olympus’ biophotonics portfolio by combining optical imaging with real-time ultrasound guidance, addressing the growing demand for minimally invasive lung sampling and enhancing diagnostic accuracy in thoracic oncology.

What Are Latest Mergers And Acquisitions In The Biophotonics Market?

In May 2024, Bruker corporation, a US-based manufacturer company acquired NanoString Technologies for $392.6 million. This acquisition will enhance Bruker's capabilities in spatial biology, especially with their nCounter Analysis System, which profiles gene and protein expression with high sensitivity and precision. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.

Regional Outlook

North America was the largest region in the biophotonics market in 2025. Western Europe was the second largest region in the biophotonics market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biophotonics Market?

The biophotonics market consists of revenues earned by entities by providing services such as optical imaging services, spectroscopy services, biosensing and lab-on-a-chip analysis services, laser-based therapeutic services, microscopy and high-resolution imaging services, and real-time biological process monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biophotonics market also includes sales of optical coherence tomography systems, fluorescence microscopy systems, Raman spectroscopy instruments, multiphoton microscopy systems, biosensor devices, and laser excitation and scanning systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biophotonics Market Report 2026?

The biophotonics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.